The Asia Pacific Coronary stents Market would witness market growth of 10.9% CAGR during the forecast period (2018 – 2024). The leading factors that drive the market are growing number of geriatric population and increasing incidence of heart failures & coronary disorders such as esophageal cancer, gall bladder cancer, and other abnormalities. In addition to the aforementioned health challenges, technological advancements in the stent systems, namely bio-absorbable stents have further propelled the market growth.
Based on Product Type, the market is segmented into Drug-eluting stents (DES), Bare-Metal Stents and Bioresorbable Vascular Scaffold. Drug-eluting stents (DES) are further classified into Polymer Based Coatings and Polymer Free Coatings. Polymer Free Coatings is segmented into Micro Structured Surface, Micro porous Surface, Slotted Tubular Surface and Nanoporous Surface. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.
Scope of the Study
Market Segmentation:
By Product Type
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 